Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update

Immunocore Reports Third Quarter 2023 Financial Results and Provides Business UpdateKIMMTRAK net revenues of £49.7 million ($60.7 million) in Q3 2...

Related Keywords

Oxfordshire ,United Kingdom ,Australia ,Finland ,Switzerland ,Canada ,Austria ,Belgium ,Italy ,France ,Rockville ,Western Australia ,Germany ,Israel ,United States ,Ukraine ,French ,John Trainer ,Clayton Robertson Morgan Warenius ,Immunocore Imm ,Bahija Jallal ,Prix Galien ,European Union ,Head Of Communications ,Immunocore Holdings ,Exchange Commission On ,Nasdaq ,European Society For Medical Oncology ,Exchange Commission ,Twitter ,European Organisation For Research ,Immunocore Reports Third Quarter ,Provides Business ,European Organisation ,New England Journal ,Chief Executive ,European Society ,Medical Oncology ,Pergamon Prize ,German Prix Galien ,Orphan Drug ,Innovative Therapeutic ,John Goll ,Senior Vice President ,Chief Accounting ,Chief Accounting Officer ,Chief Operating ,Chief Financial Officer ,Against Virus ,Against Cancer ,Release Syndrome ,Product Characteristics ,Private Securities Litigation Reform Act ,Annual Report ,Morgan Warenius ,Consolidated Statements ,Months Ended ,Months Ended September ,Financial Position ,Consolidated Statement ,Cash Flows ,Each Period Presented ,